GENI - Genius Sports Limited
NYSE
->
Communication Services
->
Internet Content & Information
London,
United Kingdom
Type: Equity
GENI price evolution
GENI
| (in millions $) | 31 Jan 2024 | 30 Oct 2023 | 30 Jul 2023 | 1 May 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $100.33 | $92 | $89.81 | $94.44 |
| Short term investments | ||||
| Net receivables | $109.89 | $105.6 | $99.29 | $82.38 |
| Inventory | $0.4 | $0.43 | $0.32 | |
| Total current assets | $244.78 | $248.1 | $222.22 | $218.41 |
| Long term investments | ||||
| Property, plant & equipment | $18.56 | $19.5 | $17.65 | $19.26 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $775.72 | $772.2 | $768.8 | $757.86 |
| Current liabilities | ||||
| Accounts payable | $57.38 | $43.7 | $23.6 | $21.36 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $182.91 | $174.7 | $148.8 | $144.76 |
| Long term debt | $0.02 | $0.03 | $0.04 | |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $202.71 | $194.8 | $167.54 | $163.96 |
| Shareholders' equity | ||||
| Retained earnings | -$1024.49 | -$986 | -$974.42 | -$964.12 |
| Other shareholder equity | -$33.06 | -$51.1 | -$33.87 | -$46.2 |
| Total shareholder equity | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 31 Jan 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $100.33 | $122.72 | $222.38 | $1 |
| Short term investments | ||||
| Net receivables | $109.89 | $71.83 | $77.34 | |
| Inventory | $0.28 | $0.53 | ||
| Total current assets | $244.78 | $236.52 | $324.68 | $1.4 |
| Long term investments | ||||
| Property, plant & equipment | $18.56 | $19.34 | $14.45 | |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $775.72 | $773.34 | $887.08 | $277.4 |
| Current liabilities | ||||
| Accounts payable | $57.38 | $33.12 | $19.88 | $0.2 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $182.91 | $171.14 | $152.81 | $0.6 |
| Long term debt | $0.02 | $7.09 | $0.07 | |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $202.71 | $196.52 | $180.91 | $10.2 |
| Shareholders' equity | ||||
| Retained earnings | -$1024.49 | -$938.95 | -$757.32 | -$0.6 |
| Other shareholder equity | -$33.06 | -$55.17 | -$0.17 | |
| Total shareholder equity | ||||
| (in millions $) | 30 Oct 2022 | 30 Jul 2022 | 1 May 2022 | 31 Jan 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $78.65 | $71.12 | ||
| Cost of revenue | ||||
| Gross Profit | $5.83 | $9.3 | ||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $39.19 | $48.99 | ||
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $0.23 | -$0.06 | ||
| Interest expense | $27.01 | $30.2 | ||
| Net income | ||||
| Net income | -$8.97 | -$4.75 | ||
| Income (for common shares) | ||||
| (in millions $) | 31 Jan 2022 | 31 Jan 2021 | ||
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $0.73 | |||
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | ||||
| Interest expense | $0.1 | |||
| Net income | ||||
| Net income | -$0.63 | |||
| Income (for common shares) | ||||
| (in millions $) | 30 Oct 2022 | 30 Jul 2022 | 1 May 2022 | 31 Jan 2022 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$43.13 | -$31.89 | -$19.5 | -$132.32 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | $410.36 | |||
| Effect of exchange rate | -$23.72 | -$13.31 | -$3.38 | -$4.14 |
| Change in cash and equivalents | -$71.98 | -$47.4 | -$48.2 | $210.59 |
| (in millions $) | 31 Jan 2022 | 31 Jan 2021 | ||
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$132.32 | -$276 | ||
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | $410.36 | $277.58 | ||
| Effect of exchange rate | -$4.14 | |||
| Change in cash and equivalents | $210.59 | $0.98 | ||
News
Fundamentals
| Market cap | $1.06B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 209.12M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | 0.48 |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.34 |
| Quick ratio | N/A |